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Cortisol is secreted by the adrenal glands when a person is facing a 
stressful situation. It stimulates a rise in blood glucose levels, to run 
faster when facing a lion, for example.
HyperCortisolemia in Alzheimer’s Disease (AD) [1] is thought to be not just 
a consequence but to have a role in the manifestation of the disease [2].
It is been reported that glucocorticoid administration increases 
Amyloid Beta formation and augments tau accumulation inside the 
brain [2], explaining how cortisol overflow could be the cause for the 
main hallmarks of the disease.
Another study researched cortisol and its impact on hippocampal 
glucose metabolism [3], but also found something else, something the 
research team barely mentioned. 
They have found that cortisol administration led to a rise in blood glucose 
levels, but only in the control group and not among Alzheimer’s patients.
“Blood collected during the positron emission tomography scans 
showed, for the normal group, a rise in plasma glucose levels, starting 
approximately 25 min after hydrocortisone administration. The AD 
group did not show this effect…” [3].
This abnormality lies in the most basic process of cortisol secretion 
leading to a rise in blood glucose levels. Plenty of research centers 
around Cortisol in AD but I couldn’t find anywhere else any mention of 
this so basic malfunction.
I urge further research, to examine if blood glucose levels in 
AD patients are in fact not responding to cortisol secretion (or 
administration). This could bring new ideas on how to solve this 
impairment and solving it could perhaps prove beneficial for AD 
treatment as a whole.
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